Circadian chemotherapy against stage IIIB-IV non-small-cell lung cancer (NSCLC) with 5-Fluorouracil (5-FU), folinic acid (FOL) and cisplatin (CDDP) via a multichannel programmable pump. Preliminary results
| Autor: | E. Laennec, P. Poirie, M. Vincent, B. Girodet, Jean-Michel Ardiet, L. Van-Straaten, A. Boisson, F. Levi, B. Guibert |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Cisplatin
Oncology Chemotherapy medicine.medical_specialty business.industry medicine.medical_treatment non-small cell lung cancer (NSCLC) Five-year survival rate respiratory system medicine.disease Malignancy respiratory tract diseases Folinic acid Fluorouracil Internal medicine Medicine business Lung cancer medicine.drug |
| Zdroj: | Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy ISBN: 9782817807843 |
| Popis: | Non-small-cell lung cancer (NSCLC) is the most common malignancy diagnosed both in the European Community and the United States. It is also the leading cause of cancer-related deaths in men. According to the new system UICC, stages IIIB and IV are generally considered as incurable. Five year survival rate is 5–10%. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|